Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Huang-long Zhi-xiao Granule for Chronic Persistent Asthma
NCT05841901Unknown
- Sponsor
- Henan University of Chinese Medicine
- Start
- Jun 2023
- Primary completion
- Feb 2024
- Modality
- Small Molecules
01
Overview
Randomised, double-blind trial in asthma comparing Huang-long Zhi-xiao Granule with Placebo (2 arms). Primary endpoints: Asthma Control Test at 52 weeks and Frequency of acute asthma attacks at 52 weeks. Status: unknown.
02
Drugs
huang-long zhi-xiao granule
03
Conditions
asthma
Beyond the preview
Go deeper on NCT05841901.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05841901.